By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genocea Biosciences 

161 1st Street
Suite 2C
Cambridge  Massachusetts    U.S.A.
Phone: 617-876-8191 Fax: 617-500-0969



Start Up

Company News
Virology Publishes Genocea Biosciences HSV-2 Antigen Discovery Paper 9/16/2014 8:30:01 AM
Genocea Biosciences Commences Phase 2a Trial For GEN-004, Universal Pneumococcal Vaccine Candidate 9/12/2014 11:00:08 AM
Genocea Biosciences Appoints Kenneth Bate To Its Board of Directors 9/11/2014 11:46:25 AM
Genocea Biosciences Presents Phase 1 Immunology Data For Novel Pneumoccocus Vaccine At ICAAC 9/8/2014 11:34:46 AM
Genocea Biosciences Reports Second Quarter 2014 Financial Results 8/6/2014 9:36:59 AM
Genocea Biosciences To Announce Second Quarter 2014 Financial Results On August 6, 2014 7/30/2014 10:51:38 AM
Genocea Biosciences HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell Responses In Vaccinated Subjects 7/22/2014 11:22:33 AM
Genocea Biosciences Commences Phase 2 Dose Optimization Trial For GEN-003 HSV-2 Immunotherapy 7/21/2014 11:17:08 AM
Genocea Biosciences Elects Not To Pursue Public Offering 7/16/2014 10:40:34 AM
Genocea Biosciences Commences Public Offering Of Common Stock 7/14/2014 1:32:08 PM